Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 149

1.

9-Nitrocamptothecin inhibits HIV-1 replication in human peripheral blood lymphocytes: a potential alternative for HIV-infection/AIDS therapy.

Hung CL, Doniger J, Palini A, Snyder SW, Radonovich MF, Brady JN, Pantazis P, Sadaie MR.

J Med Virol. 2001 Jul;64(3):238-44.

PMID:
11424110
2.
3.

T30177, an oligonucleotide stabilized by an intramolecular guanosine octet, is a potent inhibitor of laboratory strains and clinical isolates of human immunodeficiency virus type 1.

Ojwang JO, Buckheit RW, Pommier Y, Mazumder A, De Vreese K, Esté JA, Reymen D, Pallansch LA, Lackman-Smith C, Wallace TL, et al.

Antimicrob Agents Chemother. 1995 Nov;39(11):2426-35.

4.

The compound 6-chloro-1,4-dihydro-4-oxo-1-(beta-D-ribofuranosyl) quinoline-3-carboxylic acid inhibits HIV-1 replication by targeting the enzyme reverse transcriptase.

Souza TM, Cirne-Santos CC, Rodrigues DQ, Abreu CM, Tanuri A, Ferreira VF, Marques IP, de Souza MC, Fontes CF, Frugulhetti IC, Bou-Habib DC.

Curr HIV Res. 2008 May;6(3):209-17.

PMID:
18473784
6.
9.

Anti-HIV activity of extracts from Calendula officinalis flowers.

Kalvatchev Z, Walder R, Garzaro D.

Biomed Pharmacother. 1997;51(4):176-80.

PMID:
9207986
10.

Inhibition of HIV-1 replication by hydroxychloroquine: mechanism of action and comparison with zidovudine.

Chiang G, Sassaroli M, Louie M, Chen H, Stecher VJ, Sperber K.

Clin Ther. 1996 Nov-Dec;18(6):1080-92.

PMID:
9001825
11.

Nucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptase.

Sharma PL, Nurpeisov V, Hernandez-Santiago B, Beltran T, Schinazi RF.

Curr Top Med Chem. 2004;4(9):895-919. Review.

PMID:
15134548
12.

Antiviral profile of HIV inhibitors in macrophages: implications for therapy.

Perno CF, Balestra E, Francesconi M, Abdelahad D, Caliò R, Balzarini J, Aquaro S.

Curr Top Med Chem. 2004;4(9):1009-15. Review.

PMID:
15134554
13.

Inhibition of replication of HIV in primary monocyte/macrophages by different antiviral drugs and comparative efficacy in lymphocytes.

Aquaro S, Perno CF, Balestra E, Balzarini J, Cenci A, Francesconi M, Panti S, Serra F, Villani N, Caliò R.

J Leukoc Biol. 1997 Jul;62(1):138-43. Review.

PMID:
9226005
14.

Tuftsin-AZT conjugate: potential macrophage targeting for AIDS therapy.

Fridkin M, Tsubery H, Tzehoval E, Vonsover A, Biondi L, Filira F, Rocchi R.

J Pept Sci. 2005 Jan;11(1):37-44.

PMID:
15635725
15.

APHS can act synergically with clinically available HIV-1 reverse transcriptase and protease inhibitors and is active against several drug-resistant HIV-1 strains in vitro.

Pereira CF, Paridaen JT, van de Bovenkamp M, Middel J, Verhoef J, Nottet HS.

J Antimicrob Chemother. 2003 May;51(5):1181-9. Epub 2003 Mar 28.

PMID:
12668583
16.

Tenofovir treatment augments anti-viral immunity against drug-resistant SIV challenge in chronically infected rhesus macaques.

Metzner KJ, Binley JM, Gettie A, Marx P, Nixon DF, Connor RI.

Retrovirology. 2006 Dec 21;3:97.

17.

Macrophages and HIV infection: therapeutical approaches toward this strategic virus reservoir.

Aquaro S, Caliò R, Balzarini J, Bellocchi MC, Garaci E, Perno CF.

Antiviral Res. 2002 Aug;55(2):209-25. Review.

PMID:
12103427
18.

Mechanism of inhibitory effect of NCC164 on replication of human immunodeficiency virus.

Nakamura M, Terada M, Matsuzaki K, Yoshida K, Ohno T.

Microbiol Immunol. 2001;45(3):217-23.

19.

Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.

Van Vaerenbergh K.

Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Review.

PMID:
11813503
20.

9-Nitrocamptothecin is an effective drug for the treatment of human lung tumors: comparison of in vitro and in vivo studies.

Han Z, Wyche JH, Sands H, Pantazis P.

Anticancer Res. 2001 May-Jun;21(3B):1823-7.

PMID:
11497265

Supplemental Content

Support Center